On November 24, 2020 SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, reported the Company’s participation in Piper Sandler’s 32nd Annual Virtual Healthcare Conference (Press release, Scynexis, NOV 24, 2020, View Source [SID1234571673]). Presentations will be available for registered attendees via the Piper Sandler conference site from November 23 to December 3, 2020. The Company will also participate in a panel discussion at Evercore ISI’s 3rd Annual HealthCONx Conference taking place on December 2, 2020.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation details:

Piper Sandler 32nd Annual Virtual Healthcare Conference:
Presentation Date: Monday, November 23 to Thursday, December 3, 2020
Presentation Time: 8:00 a.m. – 5:00 p.m. ET
Webcast:
Link

Evercore ISI 3rd Annual HealthCONx Conference:
Panel Discussion Topic:
No Fungus Among Us: Addressing an Important Need with Cidara, F2G, and SCYNEXIS
Presentation Date: Wednesday, December 2, 2020
Presentation Time: 11:20 a.m. – 12:05 p.m. ET

A webcast of both presentation recordings will be available for 30 days and can be found on the Scynexis website at: View Source